Finally, the possible prognostic power of PCDHB cluster methylation was compared to that of the SFN gene in a multivariate model to take into account the clinically relevant parameters considered for the risk stratification of stage 4 NB patients [3]. The gene discussed is SFN; the disease is neuroblastoma.